Actively Recruiting
Evaluating PSMA PETCT to Guide Pelvic Lymph Node Removal in Men Undergoing Prostatectomy for Prostate Cancer
Led by Canisius-Wilhelmina Hospital · Updated on 2025-02-21
706
Participants Needed
1
Research Sites
56 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether using Prostate-Specific Membrane Antigen Positron Emission TomographyComputed Tomography PSMA PETCT to select prostate cancer patients for extended pelvic lymph node dissection ePLND can reduce the number of these procedures and lower healthcare costs and patient complications. The study compares this approach to the current European guideline standard, which recommends ePLND for patients with a nomogram-calculated lymph node involvement risk greater than 5%. The goal is to see if the PSMA PETCT triage strategy can maintain similar disease outcomes while reducing intervention burden. Participants are randomized into two groups. In the intervention group, patients undergo robot-assisted radical prostatectomy RARP with ePLND only if PSMA PETCT shows suspected lymph node involvement miN1 otherwise, ePLND is omitted. The control group receives RARP plus ePLND based on the nomogram risk according to current guidelines. The study includes patients with biopsy-confirmed prostate cancer without distant metastasis who are candidates for surgery. The trial assesses the cost-effectiveness and safety of the PSMA PETCT triage method. Throughout the study, participants are monitored for biochemical recurrence over two years after surgery, which is the primary outcome. Secondary outcomes include the number of ePLNDs performed, surgery-related complications, initiation of additional treatments, metastasis-free survival, patient-reported quality of life, and health care costs tracked up to five years post-surgery. Data collection includes imaging, surgical outcomes, adverse events, and questionnaires to evaluate sexual function and overall health status.
CONDITIONS
Brief Title
Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients
Research Team
L
Lieke Wever
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here